U.K. ad watchdog investigating Reckitt TV promo; Genmab exec throws cold water on dividend hopes;

@FiercePharma: China's Jiangsu Hansoh Pharmaceutical seeks $1.5B via HKEx IPO. FierceAsiaPharma story | Follow @FiercePharma

@EricPFierce: AstraZeneca closing Indian API plant that Swedish regulators slammed in an inspection report. FiercePharmaManufacturing story | Follow @EricPFierce

@CarlyHFierce: Roche challenges hometown rival Novartis with new targeted lung-cancer med Alecensa. More from FiercePharmaMarketing | Follow @CarlyHFierce

> Britain's advertising watchdog is investigating a Reckitt Benckiser TV ad for Nurofen Express pain tablets, saying it may have misled consumers with unfounded claims. Report

> The Danish drugmaker Genmab does not expect to pay a dividend in the near future because it sees a need to reinvest in its business, a company executive said. Report

> GlaxoSmithKline ($GSK) teamed up with Comic Relief in a 5-year partnership to fight malaria with grants to organizations working in five countries where the disease is endemic. Report | Release

Medical Device News

@FierceMedDev: ICYMI yesterday: Cleveland Clinic-partnered low-cost MRI provider nabs $6.5M to kick off national expansion. Article | Follow @FierceMedDev

@EmilyWFierce: ICYMI Friday: Lab experts lash out at move to beef up regulation of lab-developed tests. Article | Follow @EmilyWFierce

> Startup raises $5M to market next-gen nausea wearable to consumers. Article

> U.S., Israel commit $12M to develop next-gen tech for first responders. Story

> In latest Covidien deal synergy, Medtronic to build $14M manufacturing facility in Ireland. Report

Biotech News

@FierceBiotech: China's WuXi raises a $290M VC fund with eyes on 'cross-border' biotech bets. Article | Follow @FierceBiotech

@JohnCFierce: The 'big' model doesn't work in drug R&D, unless you're doing a big, focused PhIII program. . Source drugs. Focus. Gamble smart. | Follow @JohnCFierce

@DamianFierce: The 2015 Biotech IPO Boom, in Requiem. Watch | Follow @DamianFierce

> Kitov Pharma's combo arthritis drug clears Phase III with an FDA filing on deck. Article

> Bristol-Myers lends Opdivo to a combo with Neon's neoantigen attack on cancer. Story

> Ted Cruz's regulatory outsourcing plan for the FDA stirs controversy. Item

> What can Gilead, Biogen and Celgene teach Big Pharma about R&D? More

Pharma Manufacturing News

> AstraZeneca adding $113M packaging, warehouse facility in U.K. Report

> Sun Pharma shedding Ohio plant with sale to Nostrum Laboratories. Item

> Capsugel gets more manufacturing expertise with two-company deal. More

> Mylan wants some payback for plants it bought from Strides cited by FDA. Story

> Sweden says AstraZeneca used questionable asthma drug API from Indian plant. Article

Drug Delivery News

> Heat-enabled chemotherapy showing promise in studies. More

> More surgeons opt for spinal anesthesia in infants. Item

> Three-drug nanoparticle cuts back resistance in metastatic melanoma. Report

> Matinas' cochleate drug delivery candidate gets FDA's infectious disease product boost. Story

> Bind advances one arm of its lung cancer nanoparticle candidate, ditches another. Article

Pharma Asia News

> Fosun Group attempts to explain as high-profile chief detained by China authorities. Report

> China connection aids $280M in new funding for Pharmaron. Item

> China's Jiangsu Hansoh Pharmaceutical seeks $1.5B via HKEx IPO. Story

> As trade pacts sprout in Asia, medical device firms need to take note. Article

> Reckitt Benckiser ordered by Australian court to pull ibuprofen painkillers. More

And Finally... A surge of callers looking to sign up for health insurance under the Affordable Care Act temporarily overwhelmed the government's capacity to enroll consumers on Monday. Report